Search research articles
Contact Us
Filters
Showing results (671-680 of 1,178) with videos related to
Page
of 118
Sort By:
Journal of Neuro-Oncology
|
September 15, 2017
Erratum to: Imaging correlates for the 2016 update on WHO classification of grade II/III gliomas: implications for IDH, 1p/19q and ATRX status
Rachel L Delfanti, David E Piccioni, Jason Handwerker, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 26, 1999
High-dose chemo/radiotherapy and autologous bone marrow or stem cell transplantation for poor-risk advanced-stage Hodgkin's disease during first partial or complete remission
A Nademanee, A Molina, H Fung, et al.
Journal of Neuro-Oncology
|
September 6, 2017
Imaging correlates for the 2016 update on WHO classification of grade II/III gliomas: implications for IDH, 1p/19q and ATRX status
Rachel L Delfanti, David E Piccioni, Jason Handwerker, et al.
Blood
|
February 26, 2000
Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors
A Krishnan, S Bhatia, M L Slovak, et al.
Bone Marrow Transplantation
|
December 15, 2010
Phase-2 trial of an intensified conditioning regimen for allogeneic hematopoietic cell transplant for poor-risk leukemia
A S Stein, M R O'Donnell, T W Synold, et al.
The Lancet. Haematology
|
February 9, 2016
Viraemia, immunogenicity, and survival outcomes of cytomegalovirus chimeric epitope vaccine supplemented with PF03512676 (CMVPepVax) in allogeneic haemopoietic stem-cell transplantation: randomised phase 1b trial
Ryotaro Nakamura, Corinna La Rosa, Jeffrey Longmate, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 21, 1998
Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies
G D Long, M D Amylon, K E Stockerl-Goldstein, et al.
Haematologica
|
December 9, 2016
Phase 1 dose-finding study of rebastinib (DCC-2036) in patients with relapsed chronic myeloid leukemia and acute myeloid leukemia
Jorge Cortes, Moshe Talpaz, Hedy P Smith, et al.
Blood Advances
|
September 28, 2021
Peritransplantation ruxolitinib administration is safe and effective in patients with myelofibrosis: a pilot open-label study
Haris Ali, Ni-Chun Tsai, Timothy Synold, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 1, 1996
Paradoxical effect of thalidomide prophylaxis on chronic graft-vs.-host disease
N J Chao, P M Parker, J C Niland, et al.
Page
of 118
Search research articles
Search
Showing results (671-680 of 1,178) with videos related to
Sort By:
Page
of 118
Journal of Neuro-Oncology
|
September 15, 2017
Erratum to: Imaging correlates for the 2016 update on WHO classification of grade II/III gliomas: implications for IDH, 1p/19q and ATRX status
Rachel L Delfanti, David E Piccioni, Jason Handwerker, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
October 26, 1999
High-dose chemo/radiotherapy and autologous bone marrow or stem cell transplantation for poor-risk advanced-stage Hodgkin's disease during first partial or complete remission
A Nademanee, A Molina, H Fung, et al.
Journal of Neuro-Oncology
|
September 6, 2017
Imaging correlates for the 2016 update on WHO classification of grade II/III gliomas: implications for IDH, 1p/19q and ATRX status
Rachel L Delfanti, David E Piccioni, Jason Handwerker, et al.
Blood
|
February 26, 2000
Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors
A Krishnan, S Bhatia, M L Slovak, et al.
Bone Marrow Transplantation
|
December 15, 2010
Phase-2 trial of an intensified conditioning regimen for allogeneic hematopoietic cell transplant for poor-risk leukemia
A S Stein, M R O'Donnell, T W Synold, et al.
The Lancet. Haematology
|
February 9, 2016
Viraemia, immunogenicity, and survival outcomes of cytomegalovirus chimeric epitope vaccine supplemented with PF03512676 (CMVPepVax) in allogeneic haemopoietic stem-cell transplantation: randomised phase 1b trial
Ryotaro Nakamura, Corinna La Rosa, Jeffrey Longmate, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
March 21, 1998
Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies
G D Long, M D Amylon, K E Stockerl-Goldstein, et al.
Haematologica
|
December 9, 2016
Phase 1 dose-finding study of rebastinib (DCC-2036) in patients with relapsed chronic myeloid leukemia and acute myeloid leukemia
Jorge Cortes, Moshe Talpaz, Hedy P Smith, et al.
Blood Advances
|
September 28, 2021
Peritransplantation ruxolitinib administration is safe and effective in patients with myelofibrosis: a pilot open-label study
Haris Ali, Ni-Chun Tsai, Timothy Synold, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 1, 1996
Paradoxical effect of thalidomide prophylaxis on chronic graft-vs.-host disease
N J Chao, P M Parker, J C Niland, et al.
Page
of 118